EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Aerosol Inhalation of a Recombinant H7N9 Hemagglutinin Antigen Elicits Systemic and Mucosal Immune Responses in Mice

Zhuoran Hou, Han Wang, Bin Zhang, Ruixi Liu, Yuli Zhang, Ye Yang, Jianxin Wu, Xuchen Hou, Xiuguo Ge, Jun Wu, Bo Liu iD

Viruses · 21.05.2026 · 18 (5) · 579

DOI: 10.3390/v18050579 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, online erschienen am 21.05.2026. Verfasst von Zhuoran Hou und 10 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin Key Laboratory of Agricultural Animal Breeding and Healthy Husbandry, College of Animal Science and Veterinary Medicine, Tianjin Agricultural…. Hauptthemen laut MEDLINE: Influenza A Virus, H7N9 Subtype, Immunity, Mucosal, Hemagglutinin Glycoproteins, Influenza Virus, Influenza Vaccines. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Institute of Biotechnology, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Highly pathogenic avian influenza A (H7N9) remains a threat to poultry health and poses a zoonotic risk, highlighting the need for vaccine antigens capable of inducing both systemic and mucosal immunity. In this study, we evaluated X33CLS-H7, a clarified cell-lysate supernatant derived from glycoengineered Pichia pastoris expressing H7 hemagglutinin, in BALB/c mice following intramuscular(i.m.) injection, nebulized inhalation, or intranasal instillation. H7 expression and hemagglutination activity were confirmed by Western blotting and hemagglutination assay, respectively. Serum HA7-specific IgG and IgA responses, hemagglutination inhibition(HI) activity, H7N9 pseudovirus neutralization, bronchoalveolar lavage fluid (BALF) antibodies, and safety readouts were assessed. After two i.m. immunizations, X33CLS-H7 induced the strongest systemic antibody responses, with an HI geometric mean titer of 1:1622 95% CI, 1:1108–1:2348 and a mean log10 NT50 of 4.62. Respiratory immunization also elicited antibody responses. After four doses, high-dose nebulized delivery produced the strongest responses among the respiratory delivery regimens, with serum IgG and IgA titers of 1.02 × 105 and 2.24 × 103, respectively, an endpoint HI GMT r of 1:457 95% CI, 1:211–1:971, and a mean log10 NT50 of 3.77 compared with 2.02 in saline controls. High-dose nebulized delivery also generated detectable HA7-specific IgG and IgA responses in bronchoalveolar lavage fluid. No overt local or systemic toxicity signals were observed under the tested conditions. These findings indicate that X33CLS-H7 retains HA7-associated antigenicity and can induce systemic and respiratory mucosal antibody responses, supporting its further evaluation as a simplified and scalable H7N9 vaccine antigen candidate.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza A Virus, H7N9 SubtypeImmunity, MucosalHemagglutinin Glycoproteins, Influenza VirusInfluenza VaccinesOrthomyxoviridae InfectionsAnimalsMice, Inbred BALB CMiceAntibodies, ViralFemaleAdministration, InhalationAerosolsImmunoglobulin GImmunoglobulin ARecombinant ProteinsBronchoalveolar Lavage FluidHemagglutination Inhibition Tests

Stichwörter der Autor:innen

A(H7N9) influenzahemagglutininimmunogenicitymucosal vaccinationyeast expression

Substanzen

Hemagglutinin Glycoproteins, Influenza VirusInfluenza VaccinesAntibodies, ViralAerosolsImmunoglobulin GImmunoglobulin ARecombinant Proteins

Autor:innen und Institutionen

  • Tianjin Key Laboratory of Agricultural Animal Breeding and Healthy Husbandry, College of Animal Science and Veterinary Medicine, Tianjin Agricultural University, Tianjin 300392, China.
  • National Key Laboratory of Advanced Biotechnology, Academy of Military Medical Sciences, Beijing 100071, China.
  • College of Animal Science and Technology, Northwest A&F University, Yangling 712100, China.
  • School of Life Sciences and Medical Engineering, Anhui University, Hefei 230601, China.

ORCID-Profile: Bo Liu

Förderung

  • Beijing Institute of Biotechnology
  • National Key Research and Development Program of China

Zitieren

APA

Hou, Z., Wang, H., Zhang, B., Liu, R., Zhang, Y., Yang, Y., Wu, J., Hou, X., Ge, X., Wu, J., & Liu, B. (2026). Aerosol Inhalation of a Recombinant H7N9 Hemagglutinin Antigen Elicits Systemic and Mucosal Immune Responses in Mice. Viruses, 18(5), 579. https://doi.org/10.3390/v18050579

Vancouver

Hou Z, Wang H, Zhang B, Liu R, Zhang Y, Yang Y, et al. Aerosol Inhalation of a Recombinant H7N9 Hemagglutinin Antigen Elicits Systemic and Mucosal Immune Responses in Mice. Viruses. 2026;18(5):579. doi:10.3390/v18050579

BibTeX
@article{Hou2026,
  author = {Hou, Zhuoran and Wang, Han and Zhang, Bin and Liu, Ruixi and Zhang, Yuli and Yang, Ye and Wu, Jianxin and Hou, Xuchen and Ge, Xiuguo and Wu, Jun and Liu, Bo},
  title = {Aerosol Inhalation of a Recombinant H7N9 Hemagglutinin Antigen Elicits Systemic and Mucosal Immune Responses in Mice},
  journal = {Viruses},
  year = {2026},
  volume = {18},
  number = {5},
  pages = {579},
  doi = {10.3390/v18050579}
}
Kostenlos starten →